Metrics
Publication
43
UN Sustainable Development Goals
Articles
All (32)
SCI-E, SSCI, AHCI (24)
SCI-E, SSCI, AHCI, ESCI (30)
ESCI (6)
Scopus (26)
TRDizin (5)
Other Publications (1)
2020
20201. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients
Peled N., Gillis R., KILIÇKAP S., Froesch P., Orlov S., Filippova E., et al.
LUNG CANCER
, vol.148, pp.48-54, 2020 (SCI-Expanded)
2020
20202. Determine the impact of hybrid capture-based comprehensive genomic profiling (CGP) on the treatment strategies in patients with solid tumors: A national, multicenter, retrospective study.
Disel U., Kose F., Bilici A., Ozguroglu M., Saglam S., Seker M., et al.
JOURNAL OF CLINICAL ONCOLOGY
, vol.38, no.15, 2020 (SCI-Expanded)
2020
20203. Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial
Demir A., Mandel N. M., PAYDAŞ S., Demir G., ER O., Turhal N. S., et al.
BALKAN MEDICAL JOURNAL
, vol.37, no.2, pp.104-107, 2020 (SCI-Expanded)
2018
20184. Prognostic Significance of Adjuvant Chemotherapy Induced Amenorrhea in Luminal A and B Subtypes
Ordu C., Pilanci K. N., Alco G., Elbuken F., Koksal U. I., Ilgun S., et al.
EUROPEAN JOURNAL OF BREAST HEALTH
, vol.14, pp.173-179, 2018 (ESCI)
2018
20185. Possible role of stress, coping strategies, and life style in the development of breast cancer
Yildirim N. K., Ozkan M., Ilgun A. S., Sarsenov D., Alco G., Aktepe F., et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
, vol.53, pp.207-220, 2018 (SCI-Expanded)
2018
20186. Impact of Personality Traits, Anxiety, Depression and Hopelessness Levels on Quality of Life in the Patients with Breast Cancer
Izci F., Sarsanov D., Erdogan Z. I., Ilgun A. S., Celebi E., Alco G., et al.
EUROPEAN JOURNAL OF BREAST HEALTH
, vol.14, pp.105-111, 2018 (ESCI)
2018
20187. Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer
İyigün Z., Duymaz T., Ilgun A. S., Alco G., Ordu C., Sarsenov D., et al.
LYMPHATIC RESEARCH AND BIOLOGY
, vol.16, pp.28-35, 2018 (SCI-Expanded)
2017
20178. Roles of Biopsychosocial Factors in the Development of Breast Cancer
Ozkan M., Yildirim N., Disci R., Ilgun A. S., Sarsenov D., Alco G., et al.
EUROPEAN JOURNAL OF BREAST HEALTH
, vol.13, pp.206-212, 2017 (ESCI)
2016
20169. Receptor discordance rate and its effects on survival in primary and recurrent breast cancer patients
Ilgun S., Sarsenov D., Erdogan Z., Ordu C., Celebi F., Pilanci K. N., et al.
JOURNAL OF BUON
, vol.21, no.6, pp.1425-1432, 2016 (SCI-Expanded)
2016
201610. Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
Sen F., Tambas M., Ozkaya K., Guveli M. E., Ciftci R., Ozkan B., et al.
MEDICINE
, vol.95, no.30, 2016 (SCI-Expanded)
2016
201611. The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer
Ordu C., McGuire K., Alco G., Pilanci K. N., Koksal U. I., Elbuken F., et al.
CUREUS
, vol.8, no.6, 2016 (ESCI)
2016
201612. True Local Recurrences after Breast Conserving Surgery have Poor Prognosis in Patients with Early Breast Cancer
Sarsenov D., Ilgun S., Ordu C., Alco G., Bozdogan A., Elbuken F., et al.
CUREUS
, vol.8, 2016 (ESCI)
2015
201513. Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer Survival and Response to Treatment
Aydiner A., Sen F., Tambas M., Ciftci R., Eralp Y., Saip P., et al.
MEDICINE
, vol.94, no.52, 2015 (SCI-Expanded)
2015
201514. Clinicopathological Data's of Advanced NSCLC Patients with ROS1 Gene Rearrangement and of Clinical Responses to Crizotinib in TURKEY
Oz B., Batur S., Eralp Y., Hasturk S., Yumuk F., Yildiz O., et al.
JOURNAL OF THORACIC ONCOLOGY
, vol.10, no.9, 2015 (SCI-Expanded)
2015
201515. Concomitant Chemoradiotherapy with Etoposide & Cisplatin versus Docetaxel & Cisplatin in Locally Advanced Non-Small Cell Lung Cancer
Eralp Y., Sen F., Tambas M., Ozkaya K., Ozkan B., Oral E. N., et al.
JOURNAL OF THORACIC ONCOLOGY
, vol.10, no.9, 2015 (SCI-Expanded)
2013
201316. The predictive and prognostic role of tumoral miRNA expression levels in patients with breast cancer (BC) treated with neoadjuvant chemotherapy (NAC)
ERALP Y., KESKIN S., GEZER U., TUKENMEZ M., MUSLUMANOGLU M. E., DALAY N., et al.
CANCER RESEARCH
, vol.73, 2013 (SCI-Expanded)
2012
201217. The Frequencies of Breast Cancer BC in Extreme Ages Changing Over Time
KESKİN S., ÇİFTÇİ R., KARABULUT S., KÜÇÜÇÜK S., YILDIZ İ., KILIÇ L., et al.
Mediterranean Oncology Journal
, vol.1, pp.46-19, 2012 (Peer-Reviewed Journal)
2011
201118. Induction Chemotherapy With Triweekly Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy With or Without Surgery in Stage III Non-Small-Cell Lung Cancer: A Phase II Study
Aydiner A., Sen F., SAGLAM E. K., Oral E. N., Eralp Y., Tas F., et al.
CLINICAL LUNG CANCER
, vol.12, no.5, pp.286-292, 2011 (SCI-Expanded, Scopus)
2009
200919. Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger
Eralp Y., Smith T. L., Altundag K., Kau S., Litton J., Valero V., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
, vol.135, no.1, pp.141-148, 2009 (SCI-Expanded)
2008
200820. Factors affecting the prognosis of breast cancer patients with brain metastases
Saip P., ÇİÇİN İ., Eralp Y., Kucucuk S., Tuzlali S., KARAGÖL H., et al.
BREAST
, vol.17, no.5, pp.451-458, 2008 (SCI-Expanded)
2008
200821. Predictive factors for local recurrence after breast conservative surgery following neoadjuvant chemotherapy: our long-term results
CABIOĞLU N., Muslumanoglu M., Igci A., Ozcinar B., Ozmen V., Dagoglu T., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, vol.23, no.2, pp.81-90, 2008 (ESCI)
2008
200822. Leptomeningeal dissemination of ovarian carcinoma through a ventriculopenitoneal shunt
Eralp Y., Saip P., Aydin Z., Berkman S., Topuz E.
GYNECOLOGIC ONCOLOGY
, vol.108, no.1, pp.248-250, 2008 (SCI-Expanded)
2007
200723. Multifocal breast cancer in women <= 35 years old
Litton J. K., Eralp Y., Gonzalez-Angulo A. M., Broglio K., Uyei A., Hortobagyi G. N., et al.
CANCER
, vol.110, no.7, pp.1445-1450, 2007 (SCI-Expanded)
2007
200724. The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer
Karagol H., Saip P., Uygun K., Caloglu M., Eralp Y., Tas F., et al.
MEDICAL ONCOLOGY
, vol.24, no.1, pp.39-43, 2007 (SCI-Expanded, Scopus)
2005
200525. Induction and concurrent chemotherapy with concomitant boost radiotherapy in non-small cell lung cancer
Oral E. N., AYDINER A., ERALP Y., TOPUZ E.
MEDICAL ONCOLOGY
, vol.22, no.4, pp.367-374, 2005 (SCI-Expanded)
2005
200526. The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.
TAS F., USTUNER Z., CAN G., ERALP Y., CAMLICA H., BASARAN M., et al.
Acta oncologica (Stockholm, Sweden)
, vol.44, no.2, pp.161-7, 2005 (SCI-Expanded, Scopus)
2004
200427. Women aged 35 years or younger with primary breast carcinoma: Disease features at presentation
Gonzalez-Angulo A. M., Broglio K., Eralp Y., Kau S., Erlichman J., Valero V., et al.
ANNALS OF ONCOLOGY
, vol.15, pp.58, 2004 (SCI-Expanded)
2003
200328. Resectable thymoma: Treatment outcome and prognostic factors in the late adolescent and adult age group
ERALP Y., AYDINER A., Kizir A., KAYTAN E., ORAL E., TOPUZ E.
CANCER INVESTIGATION
, vol.21, no.5, pp.737-743, 2003 (SCI-Expanded)
2001
200129. Thymidine labeling index in epithelial ovarian cancer
Salihoglu Y., Bilir A., Aydiner A., ERKAN M., TUZLALI S., ERALP Y.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
, vol.75, no.2, pp.171-176, 2001 (SCI-Expanded)
2000
200030. Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer.
TOPUZ E., AYDINER A., Saip P. M., ERALP Y., TAS F., Salihoglu Y., et al.
European journal of gynaecological oncology
, vol.21, no.6, pp.599-602, 2000 (SCI-Expanded, Scopus)
2000
200031. The role of chemotherapy in malignant mixed mullerian tumors of the female genital tract.
TOPUZ E., ERALP Y., AYDINER A., Saip P. M., TAS F., YAVUZ E., et al.
ANNALS OF ONCOLOGY
, vol.11, pp.87-88, 2000 (SCI-Expanded)
1998
199832. [Meta-analysis of determining the pathogen eradicating efficacy of various therapeutic regimens in Helicobacter pylori infection].
Dobrucali A. M., CANBAKAN B., CANBAKAN M., BAGATUR N., UZUNISMAIL H., ERALP Y., et al.
Wiener medizinische Wochenschrift (1946)
, vol.148, pp.464-8, 1998 (Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
2019
20191. Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey
Demirci U., GÖKMEN E., Eralp Y., Gunduz S., SEZGİN GÖKSU S., KORKMAZ T., et al.
San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 10 - 14 December 2019, vol.80, (Summary Text)
2018
20182. Long-term effective local control in patients presenting with T4 disease and treated with breast-conserving therapy after neoadjuvant chemotherapy
Tukenmez M., Trablus D. C., Ozkurt E., Cabioglu N., Dogan S., Emirikci S., et al.
19th Annual Meeting of the American-Society-of-Breast-Surgeons, Florida, United States Of America, 2 - 06 May 2018, vol.25, pp.530-531, (Summary Text)
2012
20123. The effect of contaminant chemoradiation on disease control and survival ın servix carsinoma
Aslay I., KÜÇÜCÜK N. S., SAİP P. M., ERALP Y., KEMİKLER G., Özbay İ., et al.
ESRTO 31, 9 - 13 May 2012, vol.103, pp.275, (Summary Text)
2012
20124. MKC yapılmış T1 2 N1 M0 hastalarda tedavi sonuçları ve prognostik faktörlerin değerlendirilmesi
KÜÇÜCÜK N. S., İRİBAŞ A., KARAMAN Ş., DAĞOĞLU R. N., SAİP P. M., ERALP Y., et al.
10. Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 19 - 23 April 2012
2008
20085. Is the sentinel lymph node biopsy accurate for patients with initially clinically axilla-positive locally advanced breast cancer after neoadjuvant chemotherapy?
OZMEN V., Muslumanoglu M. E., IGCI A., CANBAY E., Ozcinar B., MUDUN A., et al.
31st Annual San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 10 - 14 December 2008, vol.69, (Summary Text)
2008
20086. LOKAL İLERİ MEME KANSERİNDE NEOADJUVAN TEDAVİ AMAÇLI ANTRASİKLİN BAZLI KEMOTERAPİ REJİMİ İLE ANTRASİKLİNE EK OLARAK VERİLEN DOSETAKSELLİ TEDAVİ YÖNTEMLERİNİN KARŞILAŞTIRILMASI
Canbay E., Özçınar B., Özmen V., Müslümanoğlu M. E., Eralp Y., Aydıner A., et al.
İSTANBUL MEME KANSERİ KONFERANSI VE ULUSAL MEME KANSERİ KONSENSUS TOPLANTISI 2008, İstanbul, Turkey, 21 - 25 October 2008, pp.247, (Full Text)
2007
20077. NEOADJUVAN KEMOTERAPİ SONRASI MEME KORUYUCU CERRAHİDE LOKAL NÜKSÜ ETKİLEYEN FAKTÖRLER: UZUN DÖNEM SONUÇLARIMIZ
Cabıoğlu N., Özçınar B., Müslümanoğlu M. E., Özmen V., İğci A., Dağoğlu T., et al.
9. ULUSAL MEME HASTALIKLARI KONGRESİ, Ankara, Turkey, 5 - 09 September 2007, pp.40, (Summary Text)
2007
20078. Size distribution o circulating cell-free DNA in sera of breast cancer aptients in course of adjuvant therapy
GEZER U., ERALP Y., AKIŞIK E. E., Akışık E. Z., SAİP P. M., Topuz E., et al.
Symposium on Circulating Nucleic Acids in Plasma Serum-V, Russia, 1 - 04 August 2007, pp.9, (Full Text)
2006
20069. The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer
Karagol H., Saip P., Uygun K., Caloglu M., Eralp Y., Tas F., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.174, (Summary Text)
1998
199810. Penicilamine ve Çinko Sülfatın, Yüksek Dozda Bakır Verilen Sıçanlarda Karaciğer ve Beyin Dokusu Bakır Düzeylerine Etkisi.
ÖZÇELİK D., Eralp Y., DURSUN Ş., Oztekin G., Uzunismail H.
XIV. Ulusal Gastroenteroloji Kongresi 12-16 Eylül 1998, İstanbul. The Turkish Journal of Gastroenterology, İstanbul, Turkey, 12 - 16 September 1998, vol.9, pp.118, (Summary Text)
200
20011. LOKAL İLERİ MEME KANSERİNDE HASTALIKSIZ VE GENEL SAĞKALIMI ETKİLEYEN FAKTÖRLER: UZUN DÖNEM SONUÇLARIMIZ
Özçınar B., Cabıoğlu N., Özmen V., Müslümanoğlu M. E., İğci A., Kecer M., et al.
9. ULUSAL MEME HASTALIKLARI KONGRESİ, Ankara, Turkey, 05 September 0200 - 09 September 2007, pp.68, (Summary Text)
Funded Projects
2012 - 2013
2012 - 2013AKCİĞER ADENOKANSERLİ HASTALARIN TÜMÖR DOKUSUNDA ÖSTROJEN RESEPTÖR-BETA, ALK EKSPRESYONU VE EGFR MUTASYON VARLIĞININ ARAŞTIRILMASI
Project Supported by Higher Education Institutions , BAP PhD
ERALP Y. (Executive)